Importantly, an in vivo xenograft model further demonstrated the significant synergistic inhibitory effect of SRSF11 knockdown after IR in HCC, as reflected by results for tumor growth and tumor weight (Fig. 2j and Supplementary Fig. 2m). Here, SRSF11 is linked to hepatocellular carcinoma.